DailyStocks Stock Article Search

765 Spam-Free Article(s) Found

Sort:

Relevance

Date

Filter:

All

DeepLinks

Article Searches

https://seekingalpha.com/news/3347901-sanofi-r-and-d-chief-retire-late-june?source=feed_news_all Apr 24, 2018 - Sanofi (NYSE:SNY) Head of Global Research and Development Elias Zerhouni, M.D., will retire effective June 30.John Reed, M.D., Ph.D., former Global Head of Pharma Research & Early Development at R 0

https://seekingalpha.com/article/4164702-mannkind-experts-pulling-numbers-orifices?source=feed_sector_healthcare Apr 23, 2018 - A discussion about the latest justifications for turning around the stalled growth in Afrezza prescriptions.Why false issues will not solve MannKind's problems.I will introduce a simple tracking metho 0

http://www.zacks.com/stock/news/300064/shire-shpg-turns-down-takedas-third-buyout-proposition?cid=CS-ZC-FT-300064 Apr 20, 2018 - Shire (SHPG) declines Takeda Pharmaceutical's third acquisition offer in a cash-stock deal. 0

https://seekingalpha.com/article/4164272-portfolio-strategy-report-investors-build-shares-bioscience-stocks?source=feed_all_articles Apr 20, 2018 - Despite the skittish trading behaviors for bioscience stocks in the prior month, we wish to elucidate why this niche is actually ripe for investing.Historical data showed that as a group, bioscience e 0

https://seekingalpha.com/article/4164257-now-see-wall-streets-38-safer-international-dividend-wallstars-april?source=feed_all_articles Apr 20, 2018 - Wall Street thrives on picking prices for equities. Nearly all my articles include Broker 1yr. Target estimates. This Wall St. Star series was suggested by a reader, Minnesota72. Nationality was. 38 o 0

http://www.zacks.com/stock/news/299815/sanofi-to-divest-european-generic-unit-streamline-business?cid=CS-ZC-FT-299815 Apr 19, 2018 - Sanofi (SNY) announces sale of its European generic unit, Zentiva, for $2.4 billion. 0

https://seekingalpha.com/article/4163867-aslan-pharmaceuticals-updates-u-s-ipo-plans?source=feed_tag_ipo_analysis Apr 18, 2018 - ASLAN Pharmaceuticals intends to raise $60 million in a U.S. IPO. The firm is developing a mid- to late-stage pipeline of cancer treatments. Pivotal trials lay ahead, but management has done well with 0

https://seekingalpha.com/article/4163824-catalyst-pipeline-portfolio-updates-strong-start-portfolio?source=feed_all_articles Apr 18, 2018 - Strong portfolio performance to date +21%.Has achieved primary goals of out-performing the XBI and SPY.Continued catalysts are expected to drive the portfolio higher, and there are many to come - the 0

http://www.zacks.com/research-daily/158498/top-analyst-reports-for-abbvie-berkshire-pepsico?cid=CS-ZC-FT-158498 Apr 17, 2018 - Top Analyst Reports for AbbVie, Berkshire & PepsiCo 0

https://seekingalpha.com/article/4163563-evelo-biosciences-files-u-s-ipo?source=feed_tag_ipo_analysis Apr 17, 2018 - Evelo Biosciences has filed to raise $100 million in an IPO although the final amount may be less.The firm is developing drug candidates using the gut-related technologies of monoclonal microbials.Jus 0

Pages: 12 3 4 5 6...77

Page 1>

http://www.nasdaq.com/symbol/sny Quote information directly from the exchange SEC filings Comparison Ownership Insiders Institutions Revenue/EPS Competitors Guru Report Analysts Pre-market Quote Consultant After hours Transcripts

https://www.google.com/finance?q=SNY Industry related info and international coverage Summary News

http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=SNY Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options